Starpharma Holdings Price to Sales Ratio 2011-2021 | SPHRY
Historical PS ratio values for Starpharma Holdings (SPHRY) over the last 10 years. The current P/S ratio for Starpharma Holdings as of July 01, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Starpharma Holdings P/S Ratio Historical Data |
Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
|
0.00 |
|
nan |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.194B |
$0.002B |
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.
|